Menu

 

Research

Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f393 (Published 4 February 2013)
Cite this as: BMJ 2013;346:f393

Recent rapid responses

Rapid responses are electronic letters to the editor. They enable our users to debate issues raised in articles published on bmj.com. Although a selection of rapid responses will be included as edited readers' letters in the weekly print issue of the BMJ, their first appearance online means that they are published articles. If you need the url (web address) of an individual response, perhaps for citation purposes, simply click on the response headline and copy the url from the browser window.

Displaying 1-2 out of 2 published

Re: Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study

7 February 2013

Dear Dr Flegg

Thank you for your observation about the mistaken percentage in Table 3.

The Percentage Perinatal mortality should be 0.74% and 1.1% (as correctly given in Table 2), not 7.4% and 11.0% in vaccinated and unvaccinated mothers respectively.

Thank you again
yours,

Fernando Rubinstein

Competing interests: None declared

Fernando A Rubinstein, physician researcher

Institute of Clinical Effectiveness and Health Policy, Ravignani 2024, CP1414CPV) CABA Argentina

Click to like:

Re: Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study

6 February 2013

There is a mistake in Table 3.

Percentage Perinatal mortality is given as 7.4% and 11.0% in vaccinated and unvaccinated mothers respectively.

The percentages should be 0.74% and 1.1% (as correctly given in Table 2)

Competing interests: None declared

Peter Flegg, Physician

Blackpool Victoria Hospital, FY8 4DF

Click to like:

Latest comments and most commented

THIS WEEK'S POLL

Read related article

See previous polls